Anti-Human RAGE-1/MOK VHH (SAA2376)

Anti-Human RAGE-1/MOK VHH (SAA2376)

Anti-Human RAGE-1/MOK VHH (SAA2376) is a highly specific and potent monoclonal antibody that targets the Receptor for Advanced Glycation End Products (RAGE) and the MOK protein. This innovative biotech product is designed to provide researchers with a powerful tool for studying the role of RAGE and MOK in various biological processes.

Biological Function

RAGE is a cell surface receptor that plays a crucial role in inflammation, immune response, and cellular signaling. It is involved in a wide range of pathologies, including diabetes, cancer, and neurodegenerative diseases. MOK is a kinase protein that has been shown to interact with RAGE and regulate its activity. By targeting both RAGE and MOK, Anti-Human RAGE-1/MOK VHH offers a unique approach to studying their functions and potential therapeutic applications.

Main Applications

Anti-Human RAGE-1/MOK VHH can be used in a variety of research applications, including Western blotting, immunoprecipitation, and immunofluorescence. It can also be used in functional studies to investigate the role of RAGE and MOK in specific biological processes. This versatile antibody is suitable for use in both in vitro and in vivo experiments, making it an essential tool for researchers in the fields of immunology, oncology, and neurobiology.

Experimental Use Cases

One potential use case for Anti-Human RAGE-1/MOK VHH is in the study of diabetic complications. RAGE has been implicated in the development of diabetic retinopathy, nephropathy, and neuropathy. By targeting RAGE and MOK, researchers can gain a better understanding of the underlying mechanisms and potentially identify new therapeutic targets.

Another potential application is in cancer research. RAGE has been shown to promote tumor growth and metastasis, and MOK has been linked to drug resistance in certain cancers. Anti-Human RAGE-1/MOK VHH can be used to investigate the role of these proteins in cancer progression and identify potential strategies for targeted therapy.

In conclusion, Anti-Human RAGE-1/MOK VHH (SAA2376) is a cutting-edge biotech product that offers a unique approach to studying the functions of RAGE and MOK. Its high specificity and potency make it an essential tool for researchers looking to advance our understanding of various diseases and potentially develop new treatments. Order now and take your research to the next level!